文献速递儿科与产科急症消化、代谢与肾脏急症

中性粒细胞减少的免疫功能正常发热儿童严重细菌感染患病率

The prevalence of serious bacterial infections in neutropenic immunocompetent febrile children.
PubMed 文献 · Am J Emerg Med · 2021-02-21
一句话结论临床怀疑低时,发热的健康中性粒细胞减少儿童严重细菌感染风险与非中性粒细胞减少儿童相似,患病率范围1.9%(<0.01%-11%)。

该系统评价与Meta分析检索PubMed、EMBASE和Web of Science至2020年8月,纳入5项研究共1693例年龄≤18岁、绝对中性粒细胞计数<1000 cells/mm3、因发热(体温>38°C)至急诊就诊并接受严重细菌感染(SBI)检查的免疫功能正常儿童。SBI患病率范围1.9%(<0.01%-11%),与无中性粒细胞减少的儿童相似;所有研究均未对每例纳入患者一致筛查SBI,每项研究均存在谱偏倚导致患病率范围宽。作者结论:若临床怀疑低,发热的健康中性粒细胞减少儿童与无中性粒细胞减少儿童的SBI风险相似。

要点

  • 纳入5项研究共1693例年龄≤18岁、ANC<1000 cells/mm3、体温>38°C至急诊就诊的免疫功能正常儿童,SBI患病率范围1.9%(<0.01%-11%)。
  • 所有研究均未对每例纳入患者一致筛查SBI,每项研究均存在谱偏倚,导致SBI患病率范围宽。
  • SBI患病率与无中性粒细胞减少的儿童相似。
  • 作者结论:若临床怀疑低,发热的健康中性粒细胞减少患儿与无中性粒细胞减少患儿的SBI风险相似。
  • 全部纳入研究均为回顾性,许多研究未对所有受试者一致筛查SBI。

适用人群与场景

  • 年龄≤18岁、绝对中性粒细胞计数(ANC)<1000 cells/mm3、因发热(体温>38°C)至急诊就诊并接受SBI检查的免疫功能正常儿童。

诊断标准与关键阈值

  • 发热定义为体温>38°C;中性粒细胞减少定义为ANC<1000 cells/mm3;SBI按各研究定义。

研究设计与关键结果

  • 系统评价与Meta分析,检索PubMed、EMBASE和Web of Science自建库至2020年8月,共识别2066条文献,最终纳入5项研究(1693例患者)。
  • SBI患病率范围1.9%(<0.01%-11%),与无中性粒细胞减少的儿童相似。
  • 所有研究均未对每例纳入患者一致筛查SBI,每项研究均存在谱偏倚导致患病率范围宽。
  • 偏倚采用Newcastle Ottawa Scale量化。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析;纳入研究均为回顾性。
  • 局限:所有纳入研究均为回顾性;许多研究未对所有受试者一致筛查SBI。

对床旁实践的改变

  • 作者结论:若临床怀疑低,发热的健康中性粒细胞减少儿童与无中性粒细胞减少儿童的SBI风险相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Febrile neutropenic immunocompromised children are at a high risk of Serious Bacterial Infections (SBI).

OBJECTIVE: This systematic review and meta-analysis report the prevalence of SBI in healthy children with febrile neutropenia.

DATA SOURCE: PubMed, EMBASE, and Web of Science from their inception to August 2020.

STUDY SELECTION: Patients with an Absolute Neutrophil Count (ANC) <1000 cells/mm3 up to 18 years of age presenting to the ED with a chief complaint of fever (temperature > 38°C) and who had a workup for SBI as defined by each study.

DATA ABSTRACTION: Data from individual studies was abstracted by a subset of the authors and checked independently by the senior author. Any discrepancies were adjudicated by the joint agreement of all the authors. We calculated the prevalence of SBI by using the number of SBI's as the numerator and the total number of febrile events in patients as the denominator. Bias in our studies was quantified by the Newcastle Ottawa Scale.

RESULTS: We identified 2066 citations of which five studies (1693 patients) our inclusion criteria. None of our reviewed studies consistently tested every included patient for SBI. Spectrum bias in every study resulted in a wide range of the SBI prevalence of 1.9% (<0.01% - 11%) similar to non-neutropenic children.

LIMITATIONS: All of our studies were retrospective and many did not consistently screen all subjects for SBI.

CONCLUSION: If the clinical suspicion is low, the risk for SBI is similar between febrile healthy neutropenic and non-neutropenic children.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hao R, Saleh M, Liang T, et al. The prevalence of serious bacterial infections in neutropenic immunocompetent febrile children. Am J Emerg Med. 2021. PMID: 33639293. doi:10.1016/j.ajem.2021.02.017

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。